Amendment Statement of Principles concerning acute myeloid leukaemia (Balance of Probabilities) (No. 34 of 2016)

Administered by Department of Veterans' Affairs

Legislation au F2016L00251 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

AMENDMENT STATEMENT OF PRINCIPLES CONCERNING

ACUTE MYELOID LEUKAEMIA

(BALANCE OF PROBABILITIES) (NO. 34 OF 2016)

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Amendment Statement of Principles concerning acute myeloid leukaemia (Balance of Probabilities) (No. 34 of 2016).

Background

2.             The Repatriation Medical Authority (the Authority) has determined, under subsections 196B(3) and (8) of the Veterans’ Entitlements Act 1986 (the VEA) Amendment Statement of Principles concerning acute myeloid leukaemia (Balance of Probabilities) (No. 34 of 2016).

3.             This Instrument amends Statement of Principles concerning acute myeloid leukaemia (No. 72 of 2015) by:

  • replacing the existing factor in subsection 9(7) concerning 'being exposed to benzene'; and
  • replacing the definition of 'being exposed to benzene' with the definition of 'being exposed to benzene as specified' in Schedule 1 – Dictionary.

Day of Commencement

4.             This Instrument also specifies a day of commencement for the amendment in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003.

Consultation

5.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to benzene as a factor in acute myeloid leukaemia in the Government Notices Gazette of 9 December 2015, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  Three submissions were received for consideration by the Authority during the investigation.

Human Rights

6.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

7.             The determining of this Instrument finalises the investigation in relation to acute myeloid leukaemia as advertised in the Government Notices Gazette of 9 December 2015.

References

8.             A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 34 of 2016

Kind of Injury, Disease or Death: Acute myeloid leukaemia

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors linking particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have acute myeloid leukaemia;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • includes a revised factor which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, acute myeloid leukaemia is connected with the circumstances of eligible service rendered by a person;
  • amends Instrument No. 72 of 2015; and
  • reflects developments in the available sound medical-scientific evidence concerning acute myeloid leukaemia which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Amendment Statement of Principles concerning acute myeloid leukaemia (Balance of Probabilities) (No. 34 of 2016) was enacted to address the gap in the existing framework for linking acute myeloid leukaemia to service for the purposes of compensation under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This legislative instrument was introduced to reflect the most recent sound medical-scientific evidence concerning acute myeloid leukaemia and to ensure that the circumstances for extending medical treatment and compensation to eligible persons are clearly defined. The Repatriation Medical Authority, which determined this Instrument, sought submissions from relevant organisations and individuals to ensure a comprehensive review and finalisation of the investigation, as advertised in the Government Notices Gazette on 9 December 2015. The policy objective of this Instrument is to facilitate claims and assessments under the Acts by specifying the circumstances in which benefits can be provided, while also ensuring compatibility with human rights and promoting the rights of veterans and their dependents. The determination of this Instrument by the Repatriation Medical Authority under subsection 196B(8) of the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004 aims to improve the quality of outcomes for claimants by aligning with the latest medical-scientific evidence. The Instrument amends the earlier Instrument No. 72 of 2015 to replace the factor concerning exposure to benzene and redefines the term to reflect current understanding. It promotes various human rights, including the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health, while ensuring these rights are exercised without discrimination.

Scope and Application

The Amendment Statement of Principles concerning acute myeloid leukaemia (Balance of Probabilities) (No. 34 of 2016) is an instrument determined under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. It applies to veterans and current or former Defence Force members who have been diagnosed with acute myeloid leukaemia, facilitating their claims for medical treatment and compensation by aligning the qualifying factors for these benefits with the most recent medical-scientific evidence. This amendment specifically replaces the previous factor concerning exposure to benzene with a more detailed definition, enhancing the accuracy of eligibility assessments for those affected by this condition. The instrument's application is national, covering all veterans and Defence Force members across Australia, and it reflects the Repatriation Medical Authority's commitment to providing up-to-date, evidence-based support to those in need. The instrument is designed to be compatible with human rights as it ensures fair and non-discriminatory access to social security, health care, and adequate living standards for affected individuals.

Key Provisions

The main operative sections of this legislation (section 2) amend the Statement of Principles concerning acute myeloid leukaemia (No. 72 of 2015) by replacing the existing factor in subsection 9(7) concerning 'being exposed to benzene' with a new factor, 'being exposed to benzene as specified', as detailed in Schedule 1 – Dictionary. This change reflects updated medical-scientific evidence and is aimed at ensuring that the criteria for linking acute myeloid leukaemia with service are based on the most current research. The amendment also replaces the definition of 'being exposed to benzene', providing more precise criteria for what constitutes exposure to benzene under the legislation. The obligations and requirements imposed by this Act are primarily on the Repatriation Medical Authority (the Authority) and the Repatriation Commission. The Authority is tasked with determining the factors linking particular kinds of injury, disease or death with service based on available sound medical-scientific evidence. This involves ensuring that the criteria for compensation and medical treatment are reasonable, proportionate, and transparent, thereby facilitating the assessment and determination of benefits for eligible claimants. The Repatriation Commission must then use these updated criteria to assess claims for compensation and medical treatment under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The legislation includes potential consequences for non-compliance or breaches of the amended Statement of Principles. While specific penalties are not detailed within the explanatory statement, breaches of legislative instruments in this area could potentially result in legal challenges or reviews by the Veterans' Review Board and the Administrative Appeals Tribunal. Non-compliance could lead to the overturning of decisions that do not adhere to the updated medical-scientific evidence, thereby impacting the rights of veterans and service personnel to receive appropriate compensation and treatment. The compatibility with human rights ensures that any legal proceedings or decisions made under this legislation do not infringe upon the rights of veterans and their dependants, as outlined in international human rights instruments. In summary, this legislation updates the criteria for linking acute myeloid leukaemia with service, ensuring they are based on the latest medical-scientific evidence. It imposes obligations on the Repatriation Medical Authority and the Repatriation Commission to use these criteria in assessing claims. While specific penalties for non-compliance are not detailed, the compatibility with human rights suggests that any legal consequences would aim to uphold the rights of veterans and service personnel.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Legislative Instrument
Concepts
Commencement Provisions
Regulatory Standards
Consultation Requirements
Catchwords
Veterans’ Entitlements Act 1986

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.